巨星醫療控股(02393.HK)擬7700萬元收購廣州弘恩醫療診斷技術20%股權
格隆匯3月27日丨巨星醫療控股(02393.HK)公佈,於2020年3月27日,公司全資附屬廣西巨星醫療器械有限公司作為買方、王凱軍先生、張書強先生、宋亞琳女士及馬博明先生(共同作為該等賣方)及目標公司廣州弘恩醫療診斷技術有限公司訂立股權轉讓協議,買方擬收購目標公司20%股本權益,代價7700萬元。
收購事項的代價為目標公司透過訂立新經銷協議,將其於指定區域經銷羅氏診斷產品的現有組織診斷業務(根據由估值師編制的估值,市值為人民幣7700萬元)全部轉讓予博朗健康。
於本公佈日期,目標公司為公司擁有70%權益的間接非全資附屬公司。於收購事項完成後,目標公司為公司擁有90%權益的非全資附屬公司。目標公司業務範圍包括醫療器械特許業務(根據《醫療器械經營許可證》)。目標公司的註冊資本為人民幣2000萬元。於本公佈日期,目標公司持有有效的《醫療器械經營許可證》,及須《醫療器械經營許可證》運作的第二類醫療器械。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.